Stock 001367 ZHEJIANG HAISEN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Zhejiang Haisen Pharmaceutical Co., Ltd.

Equities

001367

CNE1000061L9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 06/06/2024 am IST 		5-day change 1st Jan Change
35.3 CNY -4.08% Intraday chart for Zhejiang Haisen Pharmaceutical Co., Ltd. -8.10% -19.70%
24/04 Zhejiang Haisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
22/04 Zhejiang Haisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Zhejiang Haisen Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of chemical active pharmaceutical ingredient (APIs) and intermediates. The Company's main drugs include digestive system drugs, antipyretic and analgesic drugs, cardiovascular APIs, antidepressants drugs, antibacterial APIs, antiviral drugs, non-steroidal anti-inflammatory and other specialty APIs and preparations. The Company mainly conducts its businesses in domestic and overseas markets.

Number of employees: 636

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chemical Raw Materials and Pharmaceutical Intermediates
100.0 %
423 100.0 % 397 100.0 % -5.99%

Sales per region

CNY in Million2022Weight2023Weight Delta
Abroad
53.4 %
194 46.0 % 212 53.4 % +9.05%
China
46.6 %
227 53.6 % 185 46.6 % -18.21%

Managers

Managers TitleAgeSince
Lin Ai CEO
 Chief Executive Officer 63 01/11/01
Ai Juan Pan DFI
 Director of Finance/CFO 62 01/98/01
Chuang Fan Wei CHM
 Chairman 65 01/98/01
Kang Kang Hu IRC
 Investor Relations Contact 51 01/98/01

Members of the board

Members of the board TitleAgeSince
Gang Zheng BRD
 Director/Board Member 49 28/20/28
Gui Rong Fang BRD
 Director/Board Member 48 28/20/28
Wen Tao Dai BRD
 Director/Board Member 53 28/20/28
Shi Yue Wang CHM
 Chairman 64 01/98/01
Lin Ai CEO
 Chief Executive Officer 63 01/11/01
Yu Xiao Wang BRD
 Director/Board Member 38 01/12/01
Ya Dai BRD
 Director/Board Member 46 01/04/01
Chuang Fan Wei CHM
 Chairman 65 01/98/01
Yang Kuan Wu BRD
 Director/Board Member 31 28/20/28
Xiang Yang Ma BRD
 Director/Board Member 54 01/98/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 68,000,000 14,738,565 ( 21.67 %) 0 21.67 %

Shareholders

NameEquities%Valuation
CITIC-Prudential Fund Management Co., Ltd.
1.207 %
201,000 1.207 % 1 M ¥
Penghua Fund Management Co., Ltd.
0.0407 %
6,778 0.0407 % 34 866 ¥
Da Cheng Fund Management Co., Ltd.
0.0286 %
4,769 0.0286 % 24 532 ¥
Ping An Fund Management Co., Ltd.
0.0247 %
4,107 0.0247 % 21 126 ¥
China Southern Asset Management Co., Ltd.
0.0229 %
3,819 0.0229 % 19 645 ¥
Huatai-PineBridge Fund Management Co., Ltd.
0.0177 %
2,954 0.0177 % 15 195 ¥
China Merchants Fund Management Co., Ltd.
0.0174 %
2,892 0.0174 % 14 876 ¥
Caitong Fund Management Co., Ltd.
0.0173 %
2,883 0.0173 % 14 830 ¥
Harfor Fund Management Co., Ltd.
0.0171 %
2,850 0.0171 % 14 660 ¥
HuaAn Fund Management Co., Ltd.
0.0137 %
2,282 0.0137 % 11 739 ¥
NameEquities%Valuation
Wang Shi Yue Family
43.65 %
22,411,200 43.65 % 115 M ¥
Shi Yue Wang
26.43 %
13,572,000 26.43 % 70 M ¥
Yu Xiao Wang
18.00 %
9,240,000 18.00 % 48 M ¥
Lin Ai
5.236 %
2,688,300 5.236 % 14 M ¥

Company contact information

Zhejiang Haisen Pharmaceutical Co., Ltd.

Xiangtan Village Liushi Street

322104, Dongyang

+

http://www.dongyang.pharm.com
address Zhejiang Haisen Pharmaceutical Co., Ltd.(001367)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG HAISEN PHARMACEUTICAL CO., LTD. Stock Zhejiang Haisen Pharmaceutical Co., Ltd.
-19.70% 35Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+43.64% 75TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+39.42% 61TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.58% 35TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.72% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+8.78% 29TCr
NOVARTIS AG Stock Novartis AG
+11.92% 22TCr
ROCHE HOLDING AG Stock Roche Holding AG
-2.62% 21TCr
PFIZER, INC. Stock Pfizer, Inc.
+0.03% 17TCr
AMGEN INC. Stock Amgen Inc.
+6.13% 16TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 001367 Stock
  4. Company Zhejiang Haisen Pharmaceutical Co., Ltd.